Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal
Clinical trial NCT04971473 · COMPLETED
Trial details
- NCT number
- NCT04971473
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-10
- Primary completion
- 2023-07-05
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.